Nitrogen mustard therapy: use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin’s disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders (1946)

Peer-Reviewed Study · Tier 1 — Primary Document · Louis S. Goodman, Maxwell M. Wintrobe, William Dameshek, Morton J. Goodman, Alfred Gilman, M. T. McLennan (JAMA 1946;132:126-132) · September 21, 1946

Louis S. Goodman et al., 1946-09-21: The first open publication of the clinical nitrogen mustard results, JAMA, 21 September 1946. The NLM record confirms the journal, date, volume, pages and MeSH indexing ('Gas Poisoning', 'Mechlorethamine'); JAMA supplies no abstract to PubMed and the full text is paywalled.

Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.

Title record (no abstract in PubMed)

Louis S. Goodman et al., 1946-09-21: The first open publication of the clinical nitrogen mustard results, JAMA, 21 September 1946. The NLM record confirms the journal, date, volume, pages and MeSH indexing ('Gas Poisoning', 'Mechlorethamine'); JAMA supplies no abstract to PubMed and the full text is paywalled. Funder/conflicts: not visible on the public record – the 1946 JAMA article carries no funding or disclosure statement that could be retrieved. Maker: nitrogen mustard produced under the U.S. wartime chemical warfare programme; no commercial manufacturer stated. Comparator: uncontrolled case series (Hodgkin's disease, lymphosarcoma, leukaemia), no placebo, no concurrent control. Full text could NOT be opened (JAMA paywall). Only the citation record was verified. Quotations from the 1946 paper must not be treated as verified until the PDF is obtained.